IssuerAnnouncementDetailsV2Portlet
Actions
Saudi Enaya Cooperative Insurance Co. Announces the Results of the Ordinary General Assembly Meeting, ( Second Meeting )
| Element List | Explanation |
|---|---|
| Introduction | The Board of Directors of Saudi Enaya Cooperative Insurance Company (“Enaya”), is pleased to announce the results of the Ordinary General Assembly meeting (the second Meeting”) that was held at 19:30 in the evening of Sunday on 29/11/1445H (corresponding to 06/06/2024G), after achieving the legal quorum for the convening of the General Assembly meeting according to the Company’s Bylaws. |
| City and Location of the General Assembly's Meeting | The headquarters of the company in Jeddah city, prince Sultan Street, through modern technology |
| Date of the General Assembly's Meeting | 2024-06-06 Corresponding to 1445-11-29 |
| Time of the General Assembly’s Meeting | 19:30 |
| Percentage of Attending Shareholders | 16.26% |
| Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees | Attendees: Mr. Khaled Qamah – Chairman Dr. Mohammed Abdullah Al-Dar - a Vice Chairman of the Company’s Board of Directors Mr. Ibrahim Mohammed Albolushi - Board Member Mr. Sultan Abdulraouf - Board Member Mr. Gunther Saacke - Board Member Mr. Abdulrahman Tolefat - Board Member Absentees: Mr. Khaled Aldhahri - Board Member Mr. Paul Schultz - Board Member |
| Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf | Mr. Ibrahim Mohammed Albolushi - Chairman of the Audit and NRC committee Dr. Mohammed Abdullah Al-Dar - Chairman of the Executive committee Mr. Gunther Saacke - Chairman of the Risk committee Mr. Abdulrahman Tolefat - Chairman of the Investment committee |
| Voting Results on the Items of the General Assembly's Meeting Agenda's | Item (1): Approving the report of the Board of Directors for the fiscal year ending on 31/12/2023. Item (2): Approving the company's auditors' report for the fiscal year ending on 31/12/2023 after discussing it. Item (3): Approving the financial statements for the year ended 31 December 2023. Item (4): Non-Approving to absolve the Board of Directors members liability during the year ended 31/12/2023. Item (5): Approving on appointing the company’s auditors from among the candidates based on the recommendation of the Board of Directors to examine, review, and audit the financial statements for the second, third, fourth and annual quarter of the fiscal year 2024 and the first quarter of the fiscal year 2025 and determine their fees. Item (6): Non-Approving on the payment of the board members remunerations (1,018,466) for year 2023. Item (7): Approving on business and contracts concluded between the company and Khaled Ahmed Al-Juffali Company and for which a member of the Board of Directors Mrs. Al-Dana Khaled Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 1,133,356 SR. This agreement has no Preferential terms. Item (8): Approving on business and contracts concluded between the company and Khaled Ahmed Al-Juffali Industrial Company and for which a member of the Board of Directors Mrs. Al-Dana Khaled Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 74,016. This agreement has no Preferential terms. Item (9): Approving on business and contracts concluded between the company and Khalid Ahmed Al-Juffali Construction Company Limited and for which a member of the Board of Directors Mrs. Al-Dana Khaled Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 116,570 SR. This agreement has no preferential terms. Item (10): Approving on business and contracts concluded between the company and Lonsdale and Associates Insurance Brokerage Company, for which a member of the Board of Directors Mrs. Dana Khaled Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 278,132 SR. for one year, This agreement has no preferential terms. Item (11): Approving on business and contracts concluded between the company and KHALID JUFFALI Construction Company Riyadh branch., in which a member of the Board of Directors Mrs. Dana Khaled Al-Juffali has an indirect interest in it, for one year, which is a medical insurance contract for the company’s employees for a year for 120,085 SR. This agreement has no preferential terms. Item (12): Approving on business and contracts concluded between the company and Lonsdale and Associates Insurance Brokerage Company Riyadh Branch, for which a member of the Board of Directors Mrs. Dana Khaled Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 36,208 SR. This agreement has no preferential terms. Item (13): Approving on business and contracts concluded between the company and Saudi Arabian Cyprus Company., in which a member of the Board of Directors Mrs. Dana Khaled Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 146,605 SR. This agreement has no preferential terms. Item (14): Approving on the business and contracts that will take place between the company and the Saudi Electronic Computer Company (SBM Ltd) in which a member of the Board of Directors Mrs. Dana Khaled Al-Juffali has an indirect interest in it which is a contract for cybersecurity monitoring services things knowing that the business during The year 2023 amounted to 345K Saudi riyals. This agreement has no preferential term. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 9.63
Net Change -0.07 (-0.72%)
Value Traded (Sar) 4,188,153.21
Volume Traded 427,616
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions